BIOCHEMICAL SOCIETY TRANSACTIONS could effectively replace the endogenous lipids of other biological membranes. Sarcoplasmic reticulum is unusual in having a highly specialized function requiring only a simple membrane protein composition. In other biological membranes, where there are large numbers of different membrane proteins, lipid heterogeneity may serve at least in part to satisfy their widely different lipid requirements. When slices of bovine cervical ganglion were incubated in the presence of appropriate amounts of dopamine, noradrenaline, PGE,? and PGF,,, cyclic AMP concentrations were significantly increased in a dose-dependent fashion. Combinations of dopamine and PGEl raised cyclic AMP concentration more than if their effects had been simply additive. Combinations of PGE, with other catecholamines or of dopamine with other prostaglandins produced effects that were simply additive. The synergism of dopamine plus PGEl does not involve action on cyclic AMP phosphodiesterase (EC 3.1.4.17) .
the E type, prompted us to investigate the possible functional correlations between dopamine, prostaglandin and cyclic AMP in sympathetic ganglia.
When slices of bovine cervical ganglion were incubated in the presence of appropriate amounts of dopamine, noradrenaline, PGE,? and PGF,,, cyclic AMP concentrations were significantly increased in a dose-dependent fashion. Combinations of dopamine and PGEl raised cyclic AMP concentration more than if their effects had been simply additive. Combinations of PGE, with other catecholamines or of dopamine with other prostaglandins produced effects that were simply additive. The synergism of dopamine plus PGEl does not involve action on cyclic AMP phosphodiesterase (EC 3.1.4.17).
The a-blocker phentolamine, as well as trillupromazine and fluphenazine, which are known to be potent dopamine antagonists, in the striatum inhibited the response to dopamine without markedly affecting the response to PGEl. These drugs, however, did not impair dopamine plus PGEi synergistic action. These experiments, in our opinion, rule out the existence of an adenylate cyclase (EC 4.6.1.1) responsive to PGEl and modulated by dopamine. In effect the survival of a dopamine plus PGEl synergism, in the presence of appropriate doses of a dopamine-receptor blocker, could hardly be explained on the basis of the latter possibility. These results may be better accounted for by the presence of a dopamine-sensitive adenylate cyclase modulated by PGEl in the ganglion. In this case, PGEl would be able to increase the number of binding sites for dopamine, thus overcoming the inhibitory action of the blocking drugs. Also the results reported in Fig. 1 Slices (40-60mg wet weight) were preincubated for 45min at 37OC in 0.7ml of oxygenated Krebs-Henseleit solution (pH7.4). After the addition of 5m-aminophylline and O~~M -G T P , the tubes were incubated for 15min; 0.1 mM-EGTA, 0.1 m~-dopamine and PGEl (0.3 or 15 pg/ml) were then added and the tubes were incubated for Smin, the h a 1 volume being 1.0ml. Reactions were blocked by homogenizing slices in cold 6 % trichloroacetic acid. Supernatants were extracted with aqueous ethyl ether, and cyclic AMP was assayed by the method of Brown et al. (1972) . Results are means of four separate experiments run in duplicate. Verticals on top of the bars represent S.E.M. Basal cyclic AMP concentration was 29.5 f 3.0pmol/mg of protein. All stimulations were significantly different from control. of the synergism is correlated with the dose of PGEl added to the slices. Since PGEl alone causes a slight but consistent increase in cyclic AMP concentration, unaffected by dopamine antagonists, the presence of a separate adenylate cyclase merely sensitive to PGEl in the ganglion has to be postulated.
It has been reported that carbachol (carbamoylcholine) is able to increase cyclic AMP of rabbit superior cervical ganglion, causing the release of dopamine from the ganglionic interneurons (S.I.F. cells); dopamine in turn directly activates adenylate cyclase in the ganglionic neurons (Greengard & Kebabian, 1974) . We observed that 0.1 mM-carbachol slightly but significantly increased cyclic AMP concentration in bovine ganglion slices and that its effect was blocked, as expected, Since adenylate cyclase in the nervous system is assumed to be localized mainly on synaptic structures (De Robertis et al., 1967) , a set of experiments was carried out on the synaptosomal fraction isolated from the ganglia. Several procedures were tested, including the method of Wilson & Cooper (1972) designed for bovine ganglia, but so far with limited success. We have been able to prepare synaptosomes containing an adenylate cyclase having a basal activity three to four times as high as the homogenate, stimulated by PGEl to an extent comparable with that observed on slices, but with a very poor sensitivity to dopamine. This fraction, moreover, did not show any modulation by PGEl of the dopamine effect. On the basis of electron microscopy and markerenzyme assay, synaptosomal preparations appeared to contain very few, if any, post-synaptic membranes. This would explain the absence of a dopamine-sensitive adenylate cyclase, localized in post-synaptic structures of bovine ganglia (Kebabian et al., 1975) . On the other hand the remarkable sensitivity of synaptosomes to PGEl would be consistent with the presence of a PGEl-sensitive adenylate cyclase in pre-ganglionic fibres.
In our opinion the data presented here, as well as other unpublished work (V. Tomasi,
, fit into the working hypothesis diagramatically presented in Fig. 2 . The stimulation of pre-ganglionic cholinergic fibres involves the activation of muscarinic receptors located on the membrane of interneurons containing dopamine and/or PGE1. The PGEl released from the interneurons regulates ganglionic transmission by acting at two separated sites: (i) in the ganglion neurons as a modulator of the dopamine receptor (dopaminesensitive adenylate cyclase); (ii) in the pre-synaptic nerve terminals by stimulating a PGE,-sensitive adenylate cyclase.
The most speculative point of this scheme is the possible existence of interneurons capable of synthesizing and releasing prostaglandins, which in turn would act on different target cells. In this connexion, it may be pointed out that evidence has been given that in the liver PGEl interacts with receptors located on the outer side of the hepatocyte membrane, activating a specific adenylate cyclase (Tomasi & Ferretti, 1975; . It has been shown in addition that the liver cellular population responsive to PGEl is different from the one metabolizing prostaglandins .
